Primary Angioplasty Versus Stenting for Endovascular Management of Intracranial Atherosclerotic Disease Following Acute Ischemic Stroke

Abstract

Background—The future of neuroendovascular treatment for intracranial atherosclerotic disease (ICAD)
has been debated since the results of SAMMPRIS reflected poor outcomes following endovascular therapy.
There is currently a large spectrum of current management strategies. We compared historical outcomes of
patients with ICAD and stroke that were treated with angioplasty-alone versus stent placement.
Methods—We extracted a population from the Nationwide Inpatient Sample (NIS) (2005–2011) and the
National Inpatient Sample (NIS) (2012) composed of patients with ICAD and infarction that were admitted
nonelectively and received endovascular revascularization. Patients treated with thrombectomy or thrombolysis were excluded. Categorical variables were compared with Chi-squared tests. Binary logistic regression was performed to evaluate mortality while controlling for age, sex, severity, and comorbidities.
Results—About 2059 admissions met our criteria. A majority were treated via stent placement (71%).
Angioplasty-alone had significantly higher mortality (17.6% vs. 8.4%, P<0.001), but no difference in iatrogenic stroke rate (3.4% vs. 3.6%, P=0.826), compared to stent placement. The adjusted odds ratio of mortality for stented patients was 0.536 (95% CI: 0.381–0.753, P<0.001) in comparison to patients treated with
angioplasty alone.
Conclusions—This study found the risk of mortality to be elevated following angioplasty alone in comparison to revascularization with stent placement, without a corresponding significant difference in iatrogenic stroke rate. This may represent selection bias due to patient characteristics not defined in the database, but it also may indicate that patients with ICAD and acute stroke have increased odds of stenosis that
is refractory to angioplasty alone and have a high risk of mortality without revascularization.